Cargando…
Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
SIMPLE SUMMARY: Osteosarcoma, Ewing’s sarcoma, and H3K27M-mutant diffuse midline glioma are rare but aggressive malignancies occurring mainly in children. Due to their rareness and often fatal course, drug development is challenging. Here, we repurposed the existing drugs dinutuximab and eliglustat...
Autores principales: | Wingerter, Arthur, El Malki, Khalifa, Sandhoff, Roger, Seidmann, Larissa, Wagner, Daniel-Christoph, Lehmann, Nadine, Vewinger, Nadine, Frauenknecht, Katrin B. M., Sommer, Clemens J., Traub, Frank, Kindler, Thomas, Russo, Alexandra, Otto, Henrike, Lollert, André, Staatz, Gundula, Roth, Lea, Paret, Claudia, Faber, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866294/ https://www.ncbi.nlm.nih.gov/pubmed/33572900 http://dx.doi.org/10.3390/cancers13030520 |
Ejemplares similares
-
HGG-03. THE GLYCOSPHINGOLIPIDS METABOLISM IS A NOVEL TARGET IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA
por: Paret, Claudia, et al.
Publicado: (2021) -
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
por: Beck, Olaf, et al.
Publicado: (2020) -
Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation
por: El Malki, Khalifa, et al.
Publicado: (2023) -
Tumor Lipids of Pediatric Papillary Renal Cell Carcinoma Stimulate Unconventional T Cells
por: Lehmann, Nadine, et al.
Publicado: (2020) -
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy
por: Paret, Claudia, et al.
Publicado: (2016)